Skip to main content
SpringerLink
Log in

Systemic Manifestations of Gastrointestinal Tract Diseases and Systemic Diseases Involving the Gastrointestinal Tract

  • Chapter
  • First Online:
Surgical Pathology of the Gastrointestinal System

  • 1834 Accesses

Abstract

Gastrointestinal symptoms are common in various systemic disorders. In addition, primary gastrointestinal disorders have extraintestinal manifestations. This chapter is expected to address common systemic diseases that involve the gastrointestinal tract, including vasculitic disorders, collagen vascular diseases, pancreatic diseases and other endocrinopathies, renal diseases, IgG4 related diseases, amyloidosis, etc., as well as describe pertinent extraintestinal manifestations of common gastrointestinal disorders such as celiac disease, inflammatory bowel disease, Whipple’s disease, polyposis syndromes, and various gastrointestinal infections. Their pathogenetic mechanism and pathologies have been discussed in detail. This unique addition in this book is expected to strengthen the reader’s knowledge of this important but neglected aspect of gastrointestinal diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12(10):561–71.

    Article  CAS  PubMed  Google Scholar 

  2. Hernandez L, Green PH. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep. 2006;8(5):383–9.

    Article  PubMed  Google Scholar 

  3. Lucendo AJ, Rodrigo L, Peña AS, editors. Extraintestinal manifestations of celiac disease and associated disorders. Advances in the understanding of gluten related pathology and the evolution of gluten-free foods. Barcelona: OmniaScience; 2015. p. 341–407.

    Google Scholar 

  4. Bilen Ş, et al. Celiac disease presenting with extraintestinal manifestations. J Clin Exp Investig/Klinik ve Deneysel Arastirmalar Dergisi. 2010;1(3).

    Google Scholar 

  5. Jericho H, Guandalini S. Extra-intestinal manifestation of celiac disease in children. Nutrients. 2018;10(6):755.

    Article  PubMed Central  CAS  Google Scholar 

  6. Laurikka P, et al. Extraintestinal manifestations of celiac disease: early detection for better long-term outcomes. Nutrients. 2018;10(8):1015.

    Article  PubMed Central  Google Scholar 

  7. van Rijn JC, et al. Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child. 2004;89(9):882–3.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Singh P, et al. Coeliac disease in patients with short stature: a tertiary care centre experience. Natl Med J India. 2015;28(4):176–80.

    PubMed  Google Scholar 

  9. Kavimandan A, et al. Prevalence of celiac disease in nutritional anemia at a tertiary care center. Indian J Gastroenterol. 2014;33(2):114–8.

    Article  PubMed  Google Scholar 

  10. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology. 2007;46(5):1650–8.

    Article  CAS  PubMed  Google Scholar 

  11. Freeman HJ. Hepatic manifestations of celiac disease. Clin Exp Gastroenterol. 2010;3:33–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Maggiore G, Caprai S. Liver involvement in celiac disease. Indian J Pediatr. 2006;73(9):809–11.

    Article  PubMed  Google Scholar 

  13. Mounajjed T, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol. 2011;136(1):128–37.

    Article  PubMed  Google Scholar 

  14. Zali MR, et al. Liver complications in celiac disease. Hepat Mon. 2011;11(5):333–41.

    PubMed  PubMed Central  Google Scholar 

  15. Freeman EB, et al. Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol. 2008;158(6):1308–14.

    Article  CAS  PubMed  Google Scholar 

  16. Collin P, et al. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23(4):464–83.

    Article  CAS  PubMed  Google Scholar 

  17. Nurmi R, et al. Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies. Dig Liver Dis. 2018;50(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  18. Syrjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant. 2000;15(1):34–42.

    Article  CAS  PubMed  Google Scholar 

  19. Wijarnpreecha K, et al. Celiac disease and the risk of kidney diseases: a systematic review and meta-analysis. Dig Liver Dis. 2016;48(12):1418–24.

    Article  PubMed  Google Scholar 

  20. Sahin I, et al. Screening for celiac disease among patients with chronic kidney disease. Ren Fail. 2012;34(5):545–9.

    Article  CAS  PubMed  Google Scholar 

  21. Halma C, Ubels F. Celiac sprue-associated membranous nephropathy. Clin Nephrol. 2007;68(3):197.

    Article  CAS  PubMed  Google Scholar 

  22. Prasad D, et al. Celiac disease associated membranous nephropathy - a rare cause or coincidence? A case report. Cases J. 2009;2:7018.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gimenez Llort A, et al. Nephrotic syndrome associated with Celiac disease. A report of five cases. Nephron. 2002;92(4):950.

    Article  CAS  PubMed  Google Scholar 

  24. Harbi H, et al. Celiac disease and focal segmental glomerulosclerosis: is it a fortuity finding? World J Nephrol Urol. 2015;4(4):264–6.

    Article  Google Scholar 

  25. Katz SI, et al. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med. 1980;93(6):857–74.

    Article  CAS  PubMed  Google Scholar 

  26. Zone JJ, et al. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest. 1990;85(3):812–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Abenavoli L, et al. Cutaneous manifestations in celiac disease. World J Gastroenterol. 2006;12(6):843–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005;128(4 Suppl 1):S87–91.

    Article  PubMed  Google Scholar 

  29. Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72(5):560–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Holmes G. Neurological and psychiatric complications in coeliac disease, in Epilepsy and other neurological disorders in coeliac disease. London: John Libby; 1997.

    Google Scholar 

  31. Nikpour S. Neurological manifestations, diagnosis, and treatment of celiac disease: a comprehensive review. Iran J Neurol. 2012;11(2):59–64.

    PubMed  PubMed Central  Google Scholar 

  32. Rosenberg RN. The molecular and genetic basis of neurologic and psychiatric disease. Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  33. Luostarinen L, et al. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry. 2003;74(4):490–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Roche Herrero MC, et al. The prevalence of headache in a population of patients with coeliac disease. Rev Neurol. 2001;32(4):301–9.

    CAS  PubMed  Google Scholar 

  35. Inaloo S, et al. A comparative study of celiac disease in children with migraine headache and a normal control group. Turk J Gastroenterol. 2011;22(1):32–5.

    Article  PubMed  Google Scholar 

  36. Chapman R, et al. Increased prevalence of epilepsy in coeliac disease. Br Med J. 1978;2(6132):250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Garwicz S, Mortensson W. Intracranial calcification mimicking the Sturge-Weber syndrome A consequence of cerebral folic acid deficiency? Pediatr Radiol. 1976;5(1):5–9.

    Article  CAS  PubMed  Google Scholar 

  38. Cheng J, et al. The association between celiac disease, dental enamel defects, and aphthous ulcers in a United States cohort. J Clin Gastroenterol. 2010;44(3):191–4.

    Article  PubMed  Google Scholar 

  39. Meyer D, et al. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol. 2001;96(1):112–9.

    CAS  PubMed  Google Scholar 

  40. Krupa-Kozak U. Pathologic bone alterations in celiac disease: etiology, epidemiology, and treatment. Nutrition. 2014;30(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  41. Bianchi M-L, Bardella MT. Bone in celiac disease. Osteoporos Int. 2008;19(12):1705–16.

    Article  PubMed  Google Scholar 

  42. Vazquez H, et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol. 2000;95(1):183.

    Article  Google Scholar 

  43. Tersigni C, et al. Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. Hum Reprod Update. 2014;20(4):582–93.

    Article  CAS  PubMed  Google Scholar 

  44. Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological history in coeliac disease. Digestion. 1994;55(4):243–6.

    Article  CAS  PubMed  Google Scholar 

  45. Ciacci C, et al. Celiac disease and pregnancy outcome. Obstet Gynecol Surv. 1996;51(11):643–4.

    Article  Google Scholar 

  46. Martinelli P, et al. Coeliac disease and unfavourable outcome of pregnancy. Gut. 2000;46(3):332–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Tursi A. Gastrointestinal motility disturbances in celiac disease. J Clin Gastroenterol. 2004;38(8):642–5.

    Article  PubMed  Google Scholar 

  48. Iovino P, et al. Esophageal impairment in adult celiac disease with steatorrhea. Am J Gastroenterol. 1998;93(8):1243–9.

    Article  CAS  PubMed  Google Scholar 

  49. Lucendo A. Esophageal manifestations of celiac disease. Dis Esophagus. 2011;24(7):470–5.

    Article  CAS  PubMed  Google Scholar 

  50. Lamanda R, Panarese A, De Stefano S. Coeliac disease and gastroesophageal non-erosive reflux: prevalence and effect of gluten free-diet. Dig Liver Dis. 2009;(41):S90.

    Google Scholar 

  51. Cuomo A, et al. Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut. 2003;52(4):514–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Green PH, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol. 2009;7(11):1210–6.

    Article  PubMed  Google Scholar 

  53. Stewart M, et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther. 2011;33(12):1340–9.

    Article  CAS  PubMed  Google Scholar 

  54. Gamboa I, et al. Acute labyrinthitis and celiac disease in pediatric age: a possible association? Otolaryngology Online J. 2017.

    Google Scholar 

  55. Hashas ASK, et al. The eyes of children with celiac disease. J Am Assoc Pediatr Ophthalmol Strabismus. 2017;21(1):48–51.

    Article  Google Scholar 

  56. Losurdo G, et al. Extra-intestinal manifestations of non-celiac gluten sensitivity: an expanding paradigm. World J Gastroenterol. 2018;24(14):1521.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Volta U, et al. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014;12(1):85.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Carroccio A, et al. Self-reported non-celiac wheat sensitivity in high school students: demographic and clinical characteristics. Nutrients. 2017;9(7):771.

    Article  PubMed Central  Google Scholar 

  59. Villanacci V, et al. Mucosal tissue transglutaminase expression in celiac disease. J Cell Mol Med. 2009;13(2):334–40.

    Article  CAS  PubMed  Google Scholar 

  60. Gorgun J, et al. Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study. Virchows Arch. 2009;455(4):363–73.

    Article  CAS  PubMed  Google Scholar 

  61. Drastich P, et al. Celiac disease markers in patients with liver diseases: a single center large scale screening study. World J Gastroenterol: WJG. 2012;18(43):6255.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Das P, et al. Immunohistochemical expression of Antitissue transglutaminase 2 in tissue injuries: an interpretation beyond celiac disease. Appl Immunohistochem Mol Morphol. 2018;26(6):425–30.

    Article  CAS  PubMed  Google Scholar 

  63. Jos J, et al. Immunoelectron-microscopic localization of immunoglobulin A and secretory component in jejunal mucosa from children with coeliac disease. Scand J Immunol. 1979;9(5):441–50.

    Article  CAS  PubMed  Google Scholar 

  64. Lancaster-Smith M, et al. Immunological phenomena in the jejunum and serum after reintroduction of dietary gluten in children with treated coeliac disease. J Clin Pathol. 1976;29(7):592–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Korponay-Szabó IR, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53(5):641–8.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Salmi TT, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55(12):1746–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Koskinen O, et al. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. J Clin Gastroenterol. 2010;44(7):483–8.

    Article  CAS  PubMed  Google Scholar 

  68. Bernstein CN, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96(4):1116–22.

    Article  CAS  PubMed  Google Scholar 

  69. Monsen U, et al. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990;85(6):711–6.

    CAS  PubMed  Google Scholar 

  70. Rankin GB, et al. National Cooperative Crohn’s Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77(4 Pt 2):914–20.

    Article  CAS  PubMed  Google Scholar 

  71. Yang SK. How does the epidemiology of inflammatory bowel disease differ between east and west? A Korean perspective. Inflamm Intest Dis. 2017;2(2):95–101.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55(5):401–12.

    Article  CAS  Google Scholar 

  73. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42(2):97–114.

    Article  PubMed  Google Scholar 

  74. Perrett AD, et al. The liver in ulcerative colitis. Q J Med. 1971;40(158):211–38.

    Article  CAS  PubMed  Google Scholar 

  75. Dew MJ, Thompson H, Allan RN. The spectrum of hepatic dysfunction in inflammatory bowel disease. Q J Med. 1979;48(189):113–35.

    CAS  PubMed  Google Scholar 

  76. Rand JA, et al. Ulcerative colitis complicated by amyloidosis. Am J Gastroenterol. 1980;74(2):185–7.

    CAS  PubMed  Google Scholar 

  77. Shorvon PJ. Amyloidosis and inflammatory bowel disease. Am J Dig Dis. 1977;22(3):209–13.

    Article  CAS  PubMed  Google Scholar 

  78. Lapidus A, et al. The prevalence of gallstone disease in a defined cohort of patients with Crohn’s disease. Am J Gastroenterol. 1999;94(5):1261–6.

    Article  CAS  PubMed  Google Scholar 

  79. Chapman RW, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21(10):870–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis. 1991;11(1):11–7.

    Article  CAS  PubMed  Google Scholar 

  81. Shepherd HA, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med. 1983;52(208):503–13.

    CAS  PubMed  Google Scholar 

  82. Schrumpf E, et al. Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis. 1988;8(3):201–9.

    Article  CAS  PubMed  Google Scholar 

  83. Yimam KK, Bowlus CL. Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev. 2014;13(4-5):445–50.

    Article  CAS  PubMed  Google Scholar 

  84. Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60(1):210–23.

    Article  CAS  PubMed  Google Scholar 

  85. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54(8):1121–5.

    Google Scholar 

  86. Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374(9701):1617–25.

    Google Scholar 

  87. Relman DA, et al. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327(5):293–301.

    Article  CAS  PubMed  Google Scholar 

  88. Baisden BL, et al. Diagnosis of Wihipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol. 2002;118(5):742–8.

    Article  CAS  PubMed  Google Scholar 

  89. Raoult D, et al. Cultivation of the bacillus of Whipple’s disease. N Engl J Med. 2000;342(9):620–5.

    Article  CAS  PubMed  Google Scholar 

  90. Raoult D, et al. Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis. 2010;16(5):776–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Fenollar F, et al. Intrafamilial circulation of Tropheryma whipplei, France. Emerg Infect Dis. 2012;18(6):949–55.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Keita AK, et al. Tropheryma whipplei prevalence strongly suggests human transmission in homeless shelters. Int J Infect Dis. 2013;17(1):e67–8.

    Article  PubMed  Google Scholar 

  93. Keita AK, et al. Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl Trop Dis. 2011;5(12):e1403.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Keita AK, Raoult D, Fenollar F. Tropheryma whipplei as a commensal bacterium. Future Microbiol. 2013;8(1):57–71.

    Article  CAS  PubMed  Google Scholar 

  95. Dobbins WO 3rd. Is there an immune deficit in Whipple’s disease? Dig Dis Sci. 1981;26(3):247–52.

    Article  PubMed  Google Scholar 

  96. Feurle GE, et al. HLA B27 and defects in the T-cell system in Whipple’s disease. Eur J Clin Investig. 1979;9(5):385–9.

    Article  CAS  Google Scholar 

  97. Dutly F, Altwegg M. Whipple's disease and “Tropheryma whippelii”. Clin Microbiol Rev. 2001;14(3):561–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Harris JK, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A. 2007;104(51):20529–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Bousbia S, et al. Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis. 2010;16(2):258–63.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Gautret P, et al. Occurrence of Tropheryma whipplei during diarrhea in Hajj pilgrims: a PCR analysis of paired rectal swabs. Travel Med Infect Dis. 2014;12(5):481–4.

    Article  PubMed  Google Scholar 

  101. Fenollar F, et al. Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis. 2010;51(5):515–21.

    Article  PubMed  Google Scholar 

  102. Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Inf Secur. 2014;69(2):103–12.

    Google Scholar 

  103. Fenollar F, Puechal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356(1):55–66.

    Article  CAS  PubMed  Google Scholar 

  104. Lagier JC, et al. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89(5):337–45.

    Article  Google Scholar 

  105. Geissdorfer W, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50(2):216–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  106. Maizel H, Ruffin JM, Dobbins WO 3rd. Whipple’s disease: a review of 19 patients from one hospital and a review of the literature since 1950. 1970. Medicine (Baltimore). 1993;72(5):343–55.

    Article  CAS  Google Scholar 

  107. Dobbins WO 3rd. Whipple’s disease. Mayo Clin Proc. 1988;63(6):623–4.

    Article  PubMed  Google Scholar 

  108. Mahnel R, et al. Immunosuppressive therapy in Whipple’s disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol. 2005;100(5):1167–73.

    Article  CAS  PubMed  Google Scholar 

  109. Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63(6):539–51.

    Article  CAS  PubMed  Google Scholar 

  110. Ayoub WT, et al. Bone destruction and ankylosis in Whipple’s disease. J Rheumatol. 1982;9(6):930–1.

    CAS  PubMed  Google Scholar 

  111. LeVine ME, Dobbins WO 3rd. Joint changes in Whipple’s disease. Semin Arthritis Rheum. 1973;3(1):79–93.

    Article  CAS  PubMed  Google Scholar 

  112. James TN, Bulkley BH. Abnormalities of the coronary arteries in Whipple’s disease. Am Heart J. 1983;105(3):481–91.

    Article  CAS  PubMed  Google Scholar 

  113. McAllister HA Jr, Fenoglio JJ Jr. Cardiac involvement in Whipple’s disease. Circulation. 1975;52(1):152–6.

    Article  PubMed  Google Scholar 

  114. Fenollar F, Lepidi H, Raoult D. Whipple’s endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis. 2001;33(8):1309–16.

    Article  CAS  PubMed  Google Scholar 

  115. Iqbal T, et al. Whipple’s disease with constrictive pericarditis: a rare disease with a rare presentation. Can J Cardiol. 2009;25(3):e89–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Wendler D, et al. Tropheryma whippelii endocarditis confirmed by polymerase chain reaction. Eur Heart J. 1995;16(3):424–5.

    Article  CAS  PubMed  Google Scholar 

  117. Bostwick DG, et al. Whipple’s disease presenting as aortic insufficiency. N Engl J Med. 1981;305(17):995–8.

    Article  CAS  PubMed  Google Scholar 

  118. Celard M, et al. Polymerase chain reaction analysis for diagnosis of Tropheryma whippelii infective endocarditis in two patients with no previous evidence of Whipple’s disease. Clin Infect Dis. 1999;29(5):1348–9.

    Article  CAS  PubMed  Google Scholar 

  119. Elkins C, Shuman TA, Pirolo JS. Cardiac Whipple’s disease without digestive symptoms. Ann Thorac Surg. 1999;67(1):250–1.

    Article  CAS  PubMed  Google Scholar 

  120. Gubler JG, et al. Whipple endocarditis without overt gastrointestinal disease: report of four cases. Ann Intern Med. 1999;131(2):112–6.

    Article  CAS  PubMed  Google Scholar 

  121. Dobbins WO 3rd. The diagnosis of Whipple’s disease. N Engl J Med. 1995;332(6):390–2.

    Article  PubMed  Google Scholar 

  122. Fantry GT, James SP. Whipple’s disease. Dig Dis. 1995;13(2):108–18.

    Article  CAS  PubMed  Google Scholar 

  123. Durand DV, et al. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore). 1997;76(3):170–84.

    Article  CAS  Google Scholar 

  124. Silbert SW, Parker E, Horenstein S. Whipple’s disease of the central nervous system. Acta Neuropathol. 1976;36(1):31–8.

    Article  CAS  PubMed  Google Scholar 

  125. Disdier P, et al. Chemosis associated with Whipple’s disease. Am J Ophthalmol. 1991;112(2):217–9.

    Article  CAS  PubMed  Google Scholar 

  126. Gillen CD, et al. Extraintestinal lymphoma in association with Whipple’s disease. Gut. 1993;34(11):1627–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Nuzum CT, Sandler RS, Paulk HT. Thrombocytosis in Whipple's disease. Gastroenterology. 1981;80(6):1465–7.

    Article  CAS  PubMed  Google Scholar 

  128. Misbah SA, et al. Whipple's disease without malabsorption: new atypical features. QJM. 1997;90(12):765–72.

    Article  CAS  PubMed  Google Scholar 

  129. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1211–28.

    Google Scholar 

  130. Gransden WR, et al. Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis. 1986;154(3):522–4.

    Article  CAS  PubMed  Google Scholar 

  131. Stein-Zamir C, et al. The changing panorama of bacterial enteric infections. Epidemiol Infect. 2009;137(11):1531–7.

    Article  CAS  PubMed  Google Scholar 

  132. Caldwell GR, et al. Shigella dysenteriae type 1 enterocolitis. Aust NZ J Med. 1986;16(3):405–7.

    Article  CAS  Google Scholar 

  133. Mao Y, Zhu C, Boedeker EC. Foodborne enteric infections. Curr Opin Gastroenterol. 2003;19(1):11–22.

    Article  CAS  PubMed  Google Scholar 

  134. Pitout JD, Church DL. Emerging gram-negative enteric infections. Clin Lab Med. 2004;24(3):605–26, vi.

    Article  PubMed  Google Scholar 

  135. Altekruse SF, et al. Campylobacter jejuni – an emerging foodborne pathogen. Emerg Infect Dis. 1999;5(1):28–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Pitkanen T, et al. Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med. 1983;143(2):215–9.

    Article  CAS  PubMed  Google Scholar 

  137. Delans RJ, et al. Hemolytic uremic syndrome after Campylobacter-induced diarrhea in an adult. Arch Intern Med. 1984;144(5):1074–6.

    Article  CAS  PubMed  Google Scholar 

  138. Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol. 2018;24(29):3204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Wirtzfeld DA, Petrelli NJ, Rodriguez-Bigas MA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol. 2001;8(4):319–27.

    Article  CAS  PubMed  Google Scholar 

  140. Schreibman IR, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol. 2005;100(2):476–90.

    Article  PubMed  Google Scholar 

  141. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med. 1994;331(25):1694–702.

    Article  CAS  PubMed  Google Scholar 

  142. Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin N Am. 2002;31(4):1107–31.

    Article  Google Scholar 

  143. Vasovcak P, et al. A novel mutation of PTEN gene in a patient with Cowden syndrome with excessive papillomatosis of the lips, discrete cutaneous lesions, and gastrointestinal polyposis. Eur J Gastroenterol Hepatol. 2007;19(6):513–7.

    Article  PubMed  Google Scholar 

  144. Salem OS, Steck WD. Cowden’s disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol. 1983;8(5):686–96.

    Article  CAS  PubMed  Google Scholar 

  145. DiLiberti JH, Weleber RG, Budden S. Ruvalcaba-Myhre-Smith syndrome: a case with probable autosomal-dominant inheritance and additional manifestations. Am J Med Genet. 1983;15(3):491–5.

    Article  CAS  PubMed  Google Scholar 

  146. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol. 1986;10(12):871–87.

    Article  CAS  PubMed  Google Scholar 

  147. Marsh DJ, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999;8(8):1461–72.

    Article  CAS  PubMed  Google Scholar 

  148. Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med. 2009;11(10):687–94.

    Article  CAS  PubMed  Google Scholar 

  149. Utsunomiya J, et al. Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J. 1975;136(2):71–82.

    CAS  PubMed  Google Scholar 

  150. Sommerhaug RG, Mason T. Peutz-Jeghers syndrome and ureteral polyposis. JAMA. 1970;211(1):120–2.

    Article  CAS  PubMed  Google Scholar 

  151. Jaeger E, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;44(6):699–703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Novelli M. The pathology of hereditary polyposis syndromes. Histopathology. 2015;66(1):78–87.

    Article  PubMed  Google Scholar 

  153. Giardiello FM, et al. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105(5):1550–2.

    Article  CAS  PubMed  Google Scholar 

  154. Valanzano R, et al. Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour. Gut. 2005;54(7):1046–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Cankaya AB, et al. Oral and maxillofacial considerations in Gardner’s Syndrome. Int J Med Sci. 2012;9(2):137–41.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Rosty C, et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol. 2012;36(6):876–82.

    Article  PubMed  PubMed Central  Google Scholar 

  157. Kalady MF, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum. 2011;54(2):164–70.

    Article  PubMed  Google Scholar 

  158. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer. 1950;3(1):74–85.

    Article  CAS  PubMed  Google Scholar 

  159. Ricaniadis N, et al. Gastrointestinal metastases from malignant melanoma. Surg Oncol. 1995;4(2):105–10.

    Article  CAS  PubMed  Google Scholar 

  160. Garwood RA, et al. A case and review of bowel perforation secondary to metastatic lung cancer. Am Surg. 2005;71(2):110–6.

    Article  PubMed  Google Scholar 

  161. Goldstein HM, Beydoun MT, Dodd GD. Radiologic spectrum of melanoma metastatic to the gastrointestinal tract. AJR Am J Roentgenol. 1977;129(4):605–12.

    Article  CAS  PubMed  Google Scholar 

  162. Morris AD, et al. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. Scand J Gastroenterol Suppl. 1981;67:131–5.

    CAS  PubMed  Google Scholar 

  163. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.[see comment][erratum appears in N Engl J Med 1999 Aug 12;341(7):548]. N Engl J Med. 1999;340(24):1888–99.

    Article  CAS  PubMed  Google Scholar 

  164. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43(11):2437–44.

    Article  CAS  PubMed  Google Scholar 

  165. Khanlou H, et al. Jejunal telangiectasias as a cause of massive bleeding in a patient with scleroderma. Rev Rhum Engl Ed. 1999;66(2):119–21.

    CAS  PubMed  Google Scholar 

  166. Lock G, et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol. 1998;25(7):1330–5.

    CAS  PubMed  Google Scholar 

  167. Reynolds JC. Immune-mediated enteric neuron dysfunction in scleroderma. [comment]. J Lab Clin Med. 1999;133(6):523–4.

    Article  CAS  PubMed  Google Scholar 

  168. Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology. 1980;79(1):155–66.

    Article  CAS  PubMed  Google Scholar 

  169. Duchini A, Sessoms SL. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome. Am J Gastroenterol. 1998;93(9):1453–6.

    Article  CAS  PubMed  Google Scholar 

  170. Domsic R, et al. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008;53(5):1163–74.

    Article  PubMed  Google Scholar 

  171. Ebert EC, Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006;40(9):769–75.

    Article  PubMed  Google Scholar 

  172. Zamost BJ, et al. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology. 1987;92(2):421–8.

    Article  CAS  PubMed  Google Scholar 

  173. Segel MC, et al. Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? Gastroenterology. 1985;89(3):485–8.

    Article  CAS  PubMed  Google Scholar 

  174. Ebert EC, Ebert EC. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol. 2008;42(1):5–12.

    Article  PubMed  Google Scholar 

  175. Marguerie C, et al. Malabsorption caused by coeliac disease in patients who have scleroderma.[see comment]. Br J Rheumatol. 1995;34(9):858–61.

    Article  CAS  PubMed  Google Scholar 

  176. Shindo K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepato-Gastroenterology. 1998;45(23):1643–50.

    CAS  PubMed  Google Scholar 

  177. Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin N Am. 1998;27(3):563–94.

    Article  CAS  Google Scholar 

  178. Lock G, et al. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol. 1997;92(5):763–71.

    CAS  PubMed  Google Scholar 

  179. Ebert EC, Ruggiero FM, Seibold JR. Intestinal perforation. A common complication of scleroderma. Dig Dis Sci. 1997;42(3):549–53.

    Article  CAS  PubMed  Google Scholar 

  180. Rohrmann CA Jr, et al. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: visceral myopathies, visceral neuropathies, and progressive systemic sclerosis. AJR Am J Roentgenol. 1984;143(5):933–41.

    Article  PubMed  Google Scholar 

  181. Cerinic MM, et al. The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin N Am. 1996;22(4):879–92.

    Article  CAS  Google Scholar 

  182. D’Angelo WA, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46(3):428–40.

    Article  PubMed  Google Scholar 

  183. Meyers AR. Progressive systemic sclerosis: gastrointestinal involvement. Clin Rheum Dis. 1979;5:115–29.

    Article  Google Scholar 

  184. Peachey RD, Creamer B, Pierce JW. Sclerodermatous involvement of the stomach and the small and large bowel. Gut. 1969;10(4):285–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  185. Fraback RC, et al. Sigmoid volvulus in two patients with progressive systemic sclerosis. J Rheumatol. 1978;5(2):195–8.

    CAS  PubMed  Google Scholar 

  186. Roberts CG, et al. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut. 2006;55(12):1697–703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  187. Meszaros WT. The colon in systemic sclerosis (scleroderma). Am J Roentgenol Radium Ther Nucl Med. 1959;82:100–2.

    CAS  PubMed  Google Scholar 

  188. Schneider A, Merikhi A, Frank BB. Autoimmune disorders: gastrointestinal manifestations and endoscopic findings. Gastrointest Endosc Clin N Am. 2006;16(1):133–51.

    Article  PubMed  Google Scholar 

  189. Shamberger RC, Crawford JL, Kirkham SE. Progressive systemic sclerosis resulting in megacolon. A case report. JAMA. 1983;250(8):1063–5.

    Article  CAS  PubMed  Google Scholar 

  190. Regan PT, Weiland LH, Geall MG. Scleroderma and intestinal perforation. Am J Gastroenterol. 1977;68(6):566–71.

    CAS  PubMed  Google Scholar 

  191. Eshraghi N, et al. Adult-onset dermatomyositis with severe gastrointestinal manifestations: case report and review of the literature. Surgery. 1998;123(3):356–8.

    Article  CAS  PubMed  Google Scholar 

  192. Hendel L, et al. Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. Scand J Gastroenterol. 1988;23(10):1182–6.

    Article  CAS  PubMed  Google Scholar 

  193. Rosson RS, Yesner R. Peroral duodenal biopsy in progressive systemic sclerosis. N Engl J Med. 1965;272:391–4.

    Article  CAS  PubMed  Google Scholar 

  194. Cobden I, et al. Small intestinal structure and passive permeability in systemic sclerosis. Gut. 1980;21(4):293–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  195. Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol. 2012;26(1):61–72.

    Article  CAS  PubMed  Google Scholar 

  196. Schneider RE, Dobbins WO 3rd. Suction biopsy of the rectal mucosa for diagnosis of arteritis in rheumatoid arthritis and related diseases. Ann Intern Med. 1968;68(3):561–8.

    Article  CAS  PubMed  Google Scholar 

  197. Raskin JB. Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Am J Med. 1999;106(5B):3S–12S.

    Article  CAS  PubMed  Google Scholar 

  198. Voutilainen M, et al. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer. Scand J Gastroenterol. 1998;33(8):811–6.

    Article  CAS  PubMed  Google Scholar 

  199. Cheatum DE, et al. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs. Clin Ther. 1999;21(6):992–1003.

    Article  CAS  PubMed  Google Scholar 

  200. Teodorescu V, et al. Gold-induced colitis: a case report and review of the literature. Mt Sinai J Med. 1993;60(3):238–41.

    CAS  PubMed  Google Scholar 

  201. Evron E, et al. Correlation between gold-induced enterocolitis and the presence of the HLA-DRB1*0404 allele. Arthritis Rheum. 1995;38(6):755–9.

    Article  CAS  PubMed  Google Scholar 

  202. Kleckner FS. Dermatomyositis and its manifestations in the gastrointestinal tract. Am J Gastroenterol. 1970;53(2):141–6.

    CAS  PubMed  Google Scholar 

  203. Jennette JC, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  204. Pagnoux C, et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides. Medicine. 2005;84(2):115–28.

    Article  PubMed  Google Scholar 

  205. Langford CA. 15. Vasculitis. J Allergy Clin Immunol. 2003;111(2):S602–12.

    Article  CAS  PubMed  Google Scholar 

  206. Camilleri M, et al. Gastrointestinal manifestations of systemic vasculitis. Q J Med. 1983;52(206):141–9.

    CAS  PubMed  Google Scholar 

  207. Scola CJ, Li C, Upchurch KS. Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore). 2008;87(1):45–51.

    Article  Google Scholar 

  208. Srigley JR, Gardiner GW. Giant cell arteritis with small bowel infarction. A case report and review of the literature. Am J Gastroenterol. 1980;73(2):157–61.

    CAS  PubMed  Google Scholar 

  209. Kurata A, et al. Multiple ulcers with perforation of the small intestine in buerger’s disease: a case report. Gastroenterology. 2003;125(3):911–6.

    Article  PubMed  Google Scholar 

  210. Olin JW. Thromboangiitis obliterans: 110 years old and little progress made. J Am Heart Assoc. 2018;7(23):e011214.

    Article  PubMed  PubMed Central  Google Scholar 

  211. Edo N, et al. Thromboangiitis obliterans with multiple large vessel involvement: case report and analysis of immunophenotypes. Cardiovasc Pathol. 2010;19(1):59–62.

    Article  PubMed  Google Scholar 

  212. Sachs IL, Klima T, Frankel NB. Thromboangiitis obliterans of the transverse colon. JAMA. 1977;238(4):336–7.

    Article  CAS  PubMed  Google Scholar 

  213. Herrington JL Jr, Grossman LA. Surgical lesions of the small and large intestine resulting from Buerger’s disease. Ann Surg. 1968;168(6):1079–87.

    Article  PubMed  PubMed Central  Google Scholar 

  214. Barron KS, et al. Report of the National Institutes of Health Workshop on Kawasaki Disease. J Rheumatol. 1999;26(1):170–90.

    CAS  PubMed  Google Scholar 

  215. Colomba C, et al. Intestinal Involvement in Kawasaki Disease. J Pediatr. 2018;202:186–93.

    Article  PubMed  Google Scholar 

  216. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61(1):100–7.

    Article  CAS  PubMed  Google Scholar 

  217. Sonmez HE, et al. Polyarteritis nodosa: lessons from 25 years of experience. Clin Exp Rheumatol. 2018.

    Google Scholar 

  218. Bassel K, Harford W. Gastrointestinal manifestations of collagen-vascular diseases. Semin Gastrointest Dis. 1995;6(4):228–40.

    CAS  PubMed  Google Scholar 

  219. Cartin-Ceba R, Peikert T, Specks U. Pathogenesis of ANCA-associated vasculitis. Curr Rheumatol Rep. 2012;14(6):481–93.

    Article  CAS  PubMed  Google Scholar 

  220. Mouthon L, Dunogue B, Guillevin L. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun. 2014;48-49:99–103.

    Article  CAS  PubMed  Google Scholar 

  221. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27(2):277–301.

    CAS  PubMed  PubMed Central  Google Scholar 

  222. Franco DL, et al. Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement. Case Rep Gastroenterol. 2014;8(3):329–36.

    Article  PubMed  PubMed Central  Google Scholar 

  223. Shimamoto C, et al. Churg-Strauss syndrome (allergic granulomatous angiitis) with peculiar multiple colonic ulcers. Am J Gastroenterol. 1990;85(3):316–9.

    CAS  PubMed  Google Scholar 

  224. Ohwada S, et al. Necrotizing granulomatous vasculitis of transverse colon and gallbladder. Hepato-Gastroenterology. 1997;44(16):1090–4.

    CAS  PubMed  Google Scholar 

  225. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus. 1998;7(4):238–58.

    Article  CAS  PubMed  Google Scholar 

  226. Brogan P, Eleftheriou D, Dillon M. Small vessel vasculitis. Pediatr Nephrol. 2010;25(6):1025–35.

    Article  PubMed  Google Scholar 

  227. Louie CY, et al. Histologic features of gastrointestinal tract biopsies in IgA vasculitis (Henoch-Schonlein Purpura). Am J Surg Pathol. 2018;42(4):529–33.

    Article  PubMed  Google Scholar 

  228. Kagimoto S. Duodenal findings on ultrasound in children with Schonlein-Henoch purpura and gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 1993;16(2):178–82.

    Article  CAS  PubMed  Google Scholar 

  229. Powers BJ, et al. Leukocytoclastic vasculitis, not associated with Henoch-Schonlein purpura, causing recurrent massive painless gastrointestinal hemorrhage. Am J Gastroenterol. 1992;87(9):1191–3.

    CAS  PubMed  Google Scholar 

  230. Morichau-Beauchant M, et al. Jejunal IgA and C3 deposition in adult Henoch-Schonlein purpura with severe intestinal manifestations. Gastroenterology. 1982;82(6):1438–42.

    Article  CAS  PubMed  Google Scholar 

  231. Babian M, Nasef S, Soloway G. Gastrointestinal infarction as a manifestation of rheumatoid vasculitis. Am J Gastroenterol. 1998;93(1):119–20.

    Article  CAS  PubMed  Google Scholar 

  232. Ebert EC, Hagspiel KD. Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol. 2011;45(5):436–41.

    Article  CAS  PubMed  Google Scholar 

  233. Turner HE, et al. Lupus or lupoid hepatitis with mesenteric vasculitis. Br J Rheumatol. 1996;35(12):1309–11.

    Article  CAS  PubMed  Google Scholar 

  234. Jones MP, Pandak WM, Moxley GF. Chronic diarrhea in essential mixed cryoglobulinemia: a manifestation of visceral vasculitis? Am J Gastroenterol. 1991;86(4):522–4.

    CAS  PubMed  Google Scholar 

  235. Reissman P, et al. Gangrenous ischemic colitis of the rectum: a rare complication of systemic lupus erythematosus. Am J Gastroenterol. 1994;89(12):2234–6.

    CAS  PubMed  Google Scholar 

  236. Marshall JB, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98(5 Pt 1):1232–8.

    Article  CAS  PubMed  Google Scholar 

  237. Saraga EP, Costa J. Idiopathic entero-colic lymphocytic phlebitis. A cause of ischemic intestinal necrosis. Am J Surg Pathol. 1989;13(4):303–8.

    Article  CAS  PubMed  Google Scholar 

  238. Saraga E, Bouzourenne H. Enterocolic (lymphocytic) phlebitis: a rare cause of intestinal ischemic necrosis: a series of six patients and review of the literature. Am J Surg Pathol. 2000;24(6):824–9.

    Article  CAS  PubMed  Google Scholar 

  239. Flaherty MJ, Lie JT, Haggitt RC. Mesenteric inflammatory veno-occlusive disease. A seldom recognized cause of intestinal ischemia. Am J Surg Pathol. 1994;18(8):779–84.

    Article  CAS  PubMed  Google Scholar 

  240. Lie JT. Mesenteric inflammatory veno-occlusive disease (MIVOD): an emerging and unsuspected cause of digestive tract ischemia. Vasa. 1997;26(2):91–6.

    CAS  PubMed  Google Scholar 

  241. Yantiss RK, et al. Idiopathic myointimal hyperplasia of mesenteric veins: an uncommon cause of ischemic colitis with distinct mucosal features. Am J Surg Pathol. 2017;41(12):1657–65.

    Article  PubMed  Google Scholar 

  242. Hatemi I, Hatemi G, Celik AF. Gastrointestinal Involvement in Behcet Disease. Rheum Dis Clin N Am. 2018;44(1):45–64.

    Article  Google Scholar 

  243. Emmi G, et al. Vascular Behcet’s syndrome: an update. Intern Emerg Med. 2018.

    Google Scholar 

  244. Hatemi I, et al. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016;95(16):e3348.

    Article  CAS  Google Scholar 

  245. Scheinfeld N. Malignant atrophic papulosis. Clin Exp Dermatol. 2007;32(5):483–7.

    Article  CAS  PubMed  Google Scholar 

  246. McFarland HR, et al. Papulosis atrophicans maligna (Köhlmeier-Degos disease): a disseminated occlusive vasculopathy. Ann Neurol. 1978;3(5):388–92.

    Article  CAS  PubMed  Google Scholar 

  247. Slavin RE, Gonzalez-Vitale JC. Segmental mediolytic arteritis: a clinical pathologic study. Lab Investig. 1976;35(1):23–9.

    CAS  PubMed  Google Scholar 

  248. Slavin RE, Cafferty L, Cartwright J Jr. Segmental mediolytic arteritis. A clinicopathologic and ultrastructural study of two cases. Am J Surg Pathol. 1989;13(7):558–68.

    Article  CAS  PubMed  Google Scholar 

  249. Naidu SG, et al. Segmental arterial mediolysis: abdominal imaging of and disease course in 111 patients. AJR Am J Roentgenol. 2018;210(4):899–905.

    Article  PubMed  Google Scholar 

  250. Fleming S, et al. Have you seen SAM? EJVES Short Rep. 2018;38:8–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  251. Bytzer P, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16):1989–96.

    Article  CAS  PubMed  Google Scholar 

  252. Ebert EC, Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon. 2005;51(12):620–63.

    Article  PubMed  Google Scholar 

  253. Shakil A, et al. Gastrointestinal complications of diabetes. [summary for patients in Am Fam Physician. 2008 Jun 15;77(12):1703-4; PMID: 18619080]. Am Fam Physician. 2008;77(12):1697–702.

    PubMed  Google Scholar 

  254. Hasler WL. Type 1 diabetes and gastroparesis: diagnosis and treatment. Curr Gastroenterol Rep. 2007;9(4):261–9.

    Article  PubMed  Google Scholar 

  255. Glouberman S. Diabetes mellitus and the gastrointestinal tract. Part II: small and large intestine and gallbladder. Ariz Med. 1977;34(3):174–5.

    CAS  PubMed  Google Scholar 

  256. Virally-Monod M, et al. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab. 1998;24(6):530–6.

    CAS  PubMed  Google Scholar 

  257. Ordog T, et al. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 2000;49(10):1731–9.

    Article  CAS  PubMed  Google Scholar 

  258. Katz LA, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med. 1966;275(24):1350–61.

    Article  CAS  PubMed  Google Scholar 

  259. Paley RG, Mitchell W, Watkinson G. Terminal colonic dilatation following intractable diarrhea in a diabetic. Gastroenterology. 1961;41:401–7.

    Article  CAS  PubMed  Google Scholar 

  260. Schmidt H, et al. Ultrastructure of diabetic autonomic neuropathy of the gastrointestinal tract. Klin Wochenschr. 1984;62(9):399–405.

    Article  CAS  PubMed  Google Scholar 

  261. Duchen LW, et al. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med. 1980;92(2 Pt 2):301–3.

    Article  CAS  PubMed  Google Scholar 

  262. Verner JV, Morrison AB. Endocrine pancreatic islet disease with diarrhea. Report of a case due to diffuse hyperplasia of nonbeta islet tissue with a review of 54 additional cases. Arch Intern Med. 1974;133(3):492–9.

    Article  CAS  PubMed  Google Scholar 

  263. Tomita T, et al. Pancreatic polypeptide cell hyperplasia with and without watery diarrhea syndrome. J Surg Oncol. 1980;14(1):11–20.

    Article  CAS  PubMed  Google Scholar 

  264. Lehy T, Roucayrol AM, Mignon M. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis. Microsc Res Tech. 2000;48(6):327–38.

    Article  CAS  PubMed  Google Scholar 

  265. Ghaferi AA, et al. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12(2):382–93.

    Article  PubMed  Google Scholar 

  266. Long RG, et al. Clinicopathological study of pancreatic and neural VIPomas. Gut. 1979;20:A934.

    Google Scholar 

  267. Shulman DI, et al. Ganglioneuromatosis involving the small intestine and pancreas of a child and causing hypersecretion of vasoactive intestinal polypeptide. J Pediatr Gastroenterol Nutr. 1996;22(2):212–8.

    Article  CAS  PubMed  Google Scholar 

  268. Krejs GJ, et al. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med. 1979;301(6):285–92.

    Article  CAS  PubMed  Google Scholar 

  269. Garbrecht N, et al. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocr Relat Cancer. 2008;15(1):229–41.

    Article  PubMed  Google Scholar 

  270. Mallinson CN, et al. A glucagonoma syndrome. Lancet. 1974;2(7871):1–5.

    Article  CAS  PubMed  Google Scholar 

  271. Jones B, et al. Villous hypertrophy of the small bowel in a patient with glucagonoma. J Comput Assist Tomogr. 1983;7(2):334–7.

    Article  CAS  PubMed  Google Scholar 

  272. Stevens FM, et al. Glucagonoma syndrome demonstrating giant duodenal villi. Gut. 1984;25(7):784–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  273. Bansal A, Gupta P, Singh H, Samanta J, Mandavdhare H, Sharma V, Sinha SK, Dutta U, Kochhar R. Gastrointestinal complications in acute and chronic pancreatitis. JGH Open. 2019;3(6):450–5.

    Article  PubMed  PubMed Central  Google Scholar 

  274. Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017;62:1745–50.

    Article  PubMed  PubMed Central  Google Scholar 

  275. McGrath C, Tsang A, Nithianandan H, Nguyen E, Bauer P, Dennis K. Malignant gastric outlet obstruction from pancreatic cancer. Case Rep Gastroenterol. 2017;11(3):511–5.

    Article  PubMed  PubMed Central  Google Scholar 

  276. Sharma S, et al. Colorectal manifestations of endocrine disease. Dis Colon Rectum. 1995;38(3):318–23.

    Article  CAS  PubMed  Google Scholar 

  277. Deen KI, Seneviratne SL, de Silva HJ. Anorectal physiology and transit in patients with disorders of thyroid metabolism. J Gastroenterol Hepatol. 1999;14(4):384–7.

    Article  CAS  PubMed  Google Scholar 

  278. Lew EA, et al. Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea. Am J Gastroenterol. 1999;94(6):1692–4.

    Article  CAS  PubMed  Google Scholar 

  279. Matosin-Matekalo M, et al. Glucose and thyroid hormone co-regulate the expression of the intestinal fructose transporter GLUT5. Biochem J. 1999;339(Pt 2):233–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  280. Papa A, et al. Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients. Hepato-Gastroenterology. 1997;44(14):426–9.

    CAS  PubMed  Google Scholar 

  281. Maser C, et al. Gastrointestinal manifestations of endocrine disease. World J Gastroenterol. 2006;12(20):3174–9.

    Article  PubMed  PubMed Central  Google Scholar 

  282. Miller LJ, Gorman CA, Go VL. Gut-thyroid interrelationships. Gastroenterology. 1978;75(5):901–11.

    Article  CAS  PubMed  Google Scholar 

  283. Marks P, Anderson J, Vincent R. Thyrotoxic myopathy presenting as dysphagia. Postgrad Med J. 1980;56(659):669–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  284. Buchholz DW. Neurogenic dysphagia: what is the cause when the cause is not obvious? Dysphagia. 1994;9(4):245–55.

    Article  CAS  PubMed  Google Scholar 

  285. Eastwood GL, et al. Reversal of lower esophageal sphincter hypotension and esophageal aperistalsis after treatment for hypothyroidism. J Clin Gastroenterol. 1982;4(4):307–10.

    Article  CAS  PubMed  Google Scholar 

  286. Borrie MJ, et al. Myxedema megacolon after external neck irradiation. J Am Geriatr Soc. 1983;31(4):228–30.

    Article  CAS  PubMed  Google Scholar 

  287. Patel R, Hughes RW Jr. An unusual case of myxedema megacolon with features of ischemic and pseudomembranous colitis. Mayo Clin Proc. 1992;67(4):369–72.

    Article  CAS  PubMed  Google Scholar 

  288. Bastenie PA. Paralytic ileus in severe hypothyroidism. Lancet. 1946;1:413–6.

    Article  CAS  PubMed  Google Scholar 

  289. Douglass RC, Jacobson SD. Pathologic changes in adult myxedema: survey of 10 necropsies. J Clin Endocrinol Metab. 1957;17(11):1354–64.

    Article  CAS  PubMed  Google Scholar 

  290. Tysk C, et al. Diagnosis and management of microscopic colitis. World J Gastroenterol. 2008;14(28):7280–8.

    Article  PubMed  PubMed Central  Google Scholar 

  291. Hanna FW, et al. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. J Endocrinol. 1997;152(2):275–81.

    Article  CAS  PubMed  Google Scholar 

  292. Guyetant S, et al. Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial disease. Hum Pathol. 1999;30(8):957–63.

    Article  CAS  PubMed  Google Scholar 

  293. St. Goar, W.T., Gastrointestinal symptoms as a clue to the diagnosis of primary hyperparathyrodism: a review of 45 cases. Ann Intern Med, 1957. 46: p. 102-118.

    Article  Google Scholar 

  294. Silverberg SJ, et al. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2(9):494–503.

    Article  PubMed  Google Scholar 

  295. Eversman JJ, Farmer RG, Brown CH. Gastrointestinal manifestations of hyperparathyroidism. Arch Intern Med. 1967;119(6):605–9.

    Article  CAS  PubMed  Google Scholar 

  296. Gardner EC, Hersh T. Primary hyperparathyroidism and the gastrointestinal tract. South Med J. 1981;74:197–9.

    Article  PubMed  Google Scholar 

  297. Palmer FJ. The clinical manifestations of primary hyperparathyroidism. Compr Ther. 1983;9(2):56–64.

    CAS  PubMed  Google Scholar 

  298. Clarkson B, et al. Clinical and metabolic study of a patient with malabsorption and hypoparathyroidism. Metabolism. 1960;9:1093–106.

    CAS  PubMed  Google Scholar 

  299. Peracchi M, Bardella MT, Conte D. Late-onset idiopathic hypoparathyroidism as a cause of diarrhoea. Eur J Gastroenterol Hepatol. 1998;10(2):163–5.

    Article  CAS  PubMed  Google Scholar 

  300. Landauer N, et al. A rare but endocrine cause of chronic diarrhea. Am J Gastroenterol. 2003;98(1):227–8.

    Article  PubMed  Google Scholar 

  301. McBrien DJ, Jones RV, Creamer B. Steatorrhea in Addison's disease. Lancet. 1963;1:25–6.

    Article  Google Scholar 

  302. Tobin MV, et al. Gastrointestinal manifestations of Addison’s disease. Am J Gastroenterol. 1989;84(10):1302–5.

    CAS  PubMed  Google Scholar 

  303. O’Leary C, et al. Coeliac disease and autoimmune Addison’s disease: a clinical pitfall. QJM. 2002;95(2):79–82.

    Article  PubMed  Google Scholar 

  304. Betterle C, et al. Celiac disease in North Italian patients with autoimmune Addison’s disease. Eur J Endocrinol. 2006;154(2):275–9.

    Article  CAS  PubMed  Google Scholar 

  305. Myhre AG, et al. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scand J Gastroenterol. 2003;38(5):511–5.

    Article  CAS  PubMed  Google Scholar 

  306. Naylor EW, Gardner EJ. Adrenal adenomas in a patient with Gardner’s syndrome. Clin Genet. 1981;20(1):67–73.

    Article  CAS  PubMed  Google Scholar 

  307. Wheeler MH, Curley IR, Williams ED. The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery. 1986;100(6):1163–9.

    CAS  PubMed  Google Scholar 

  308. Dayal Y, et al. Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. Am J Surg Pathol. 1986;10(5):348–57.

    Article  CAS  PubMed  Google Scholar 

  309. Mullen JP, et al. Pathogenesis and pharmacologic management of pseudo-obstruction of the bowel in pheochromocytoma. Am J Med Sci. 1985;290(4):155–8.

    Article  CAS  PubMed  Google Scholar 

  310. Khafagi FA, Lloyd HM, Gough IR. Intestinal pseudo-obstruction in pheochromocytoma. Aust N Z J Med. 1987;17(2):246–8.

    Article  CAS  PubMed  Google Scholar 

  311. Nigawara K, et al. A case of recurrent malignant pheochromocytoma complicated by watery diarrhea, hypokalemia, achlorhydria syndrome. J Clin Endocrinol Metab. 1987;65(5):1053–6.

    Article  CAS  PubMed  Google Scholar 

  312. Wu HW, et al. Pheochromocytoma presented as intestinal pseudo-obstruction and hyperamylasemia. Am J Emerg Med. 2008;26(8):971 e1–4.

    Article  Google Scholar 

  313. Szmulowicz UM, et al. Ischemic colitis: an uncommon manifestation of pheochromocytoma. Am Surg. 2007;73(4):400–3.

    Article  PubMed  Google Scholar 

  314. Smith SL, et al. Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc. 2002;77(1):97–100.

    Article  PubMed  Google Scholar 

  315. Ikuta S, et al. Watery diarrhea, hypokalemia and achlorhydria syndrome due to an adrenal pheochromocytoma. World J Gastroenterol. 2007;13(34):4649–52.

    Article  PubMed  PubMed Central  Google Scholar 

  316. Vazquez-Quintana E, et al. Pheocromocytoma and gastrointestinal bleeding. Am Surg. 1995;61(11):937–9.

    CAS  PubMed  Google Scholar 

  317. Ali RA, et al. Gastroesophageal reflux disease in pregnancy. Best Pract Res Clin Gastroenterol. 2007;21(5):793–806.

    Article  PubMed  Google Scholar 

  318. Cullen G, et al. Constipation and pregnancy. Best Pract Res Clin Gastroenterol. 2007;21(5):807–18.

    Article  PubMed  Google Scholar 

  319. Keller J, et al. The spectrum and treatment of gastrointestinal disorders during pregnancy. Nat Clin Pract Gastroenterol Hepatol. 2008;5(8):430–43.

    Article  PubMed  Google Scholar 

  320. Ismail SK, et al. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol. 2007;21(5):755–69.

    Article  PubMed  Google Scholar 

  321. Popovic V, et al. Increased incidence of neoplasia in patients with pituitary adenomas. 1998.

    Google Scholar 

  322. Colao A, et al. The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. J Clin Endocrinol Metab. 2007;92(10):3854–60.

    Article  CAS  PubMed  Google Scholar 

  323. Resmini E, et al. Computed Tomography Colonography in Acromegaly. J Clin Endocrinol Metab. 2009;94(1):218–22.

    Article  CAS  PubMed  Google Scholar 

  324. Perniola R. Twenty Years of AIRE. Front Immunol. 2018;9:98.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  325. Ohsie S, et al. A paucity of colonic enteroendocrine and/or enterochromaffin cells characterizes a subset of patients with chronic unexplained diarrhea/malabsorption. Hum Pathol. 2009;40(7):1006–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  326. Cortina G, et al. Enteroendocrine cell dysgenesis and malabsorption, a histopathologic and immunohistochemical characterization. Hum Pathol. 2007;38(4):570–80.

    Article  CAS  PubMed  Google Scholar 

  327. Peterson P, Peltonen L. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. J Autoimmun. 2005;25(Suppl):49–55.

    Article  CAS  PubMed  Google Scholar 

  328. Tan QKG, Louie RJ, Sleasman JW, IPEX Syndrome, in GeneReviews((R)), Adam MP, et al., editors. University of Washington, Seattle GeneReviews is a registered trademark of the University of Washington, Seattle. Seattle (WA): All rights reserved; 1993.

    Google Scholar 

  329. Giusti F, et al. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine. 2017;58(2):349–59.

    Article  CAS  PubMed  Google Scholar 

  330. Moline J, Eng C. Multiple endocrine neoplasia type 2: an overview. Genet Med. 2011;13(9):755–64.

    Article  CAS  PubMed  Google Scholar 

  331. DeLellis RA, et al. Multiple endocrine neoplasia (MEN) syndromes: cellular origins and interrelationships. Int Rev Exp Pathol. 1986;28:163–215.

    CAS  PubMed  Google Scholar 

  332. Grobmyer SR, et al. Colonic manifestations of multiple endocrine neoplasia type 2B: report of four cases. Dis Colon Rectum. 1999;42(9):1216–9.

    Article  CAS  PubMed  Google Scholar 

  333. Cope R, Schleinitz PF. Multiple endocrine neoplasia, type 2b, as a cause of megacolon. Am J Gastroenterol. 1983;78(12):802–5.

    CAS  PubMed  Google Scholar 

  334. Carney AJ, Hayles AB. Alimentary tract manifestations of multiple endocrine neoplasia, type 2b. Mayo Clin Proc. 1977;52:543–8.

    CAS  PubMed  Google Scholar 

  335. Snover DC, Weigent CE, Sumner HW. Diffuse mucosal ganglioneuromatosis of the colon associated with adenocarcinoma. Am J Clin Pathol. 1981;75(2):225–9.

    Article  CAS  PubMed  Google Scholar 

  336. Weidner N, Flanders DJ, Mitros FA. Mucosal ganglioneuromatosis associated with multiple colonic polyps. Am J Surg Pathol. 1984;8(10):779–86.

    Article  CAS  PubMed  Google Scholar 

  337. Perkins JT, Blackstone MO, Riddell RH. Adenomatous polyposis coli and multiple endocrine neoplasia type 2b. A pathogenetic relationship. Cancer. 1985;55(2):375–81.

    Article  CAS  PubMed  Google Scholar 

  338. Lewis CE, Yeh MW. Inherited endocrinopathies: an update. Mol Genet Metab. 2008;94(3):271–82.

    Article  CAS  PubMed  Google Scholar 

  339. Van Vlem B, et al. Dyspepsia and gastric emptying in chronic renal failure patients. Clin Nephrol. 2001;56(4):302–7.

    PubMed  Google Scholar 

  340. Schoonjans R, et al. Dyspepsia and gastroparesis in chronic renal failure: the role of Helicobacter pylori. Clin Nephrol. 2002;57(3):201–7.

    Article  CAS  PubMed  Google Scholar 

  341. Hirako M, et al. Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J Gastroenterol. 2005;40(12):1116–22.

    Article  PubMed  Google Scholar 

  342. Boyle JM, Johnston B. Acute upper gastrointestinal hemorrhage in patients with chronic renal disease. Am J Med. 1983;75(3):409–12.

    Article  CAS  PubMed  Google Scholar 

  343. Mitchell CJ, et al. Gastric function and histology in chronic renal failure. J Clin Pathol. 1979;32(3):208–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  344. Zuckerman GR, et al. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med. 1985;102(5):588–92.

    Article  CAS  PubMed  Google Scholar 

  345. Sohal AS, et al. Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res. 2006;118(3):417–22.

    Article  CAS  PubMed  Google Scholar 

  346. Wesdorp RIC, et al. Gastrin and gastric acid secretion in renal failure. Am J Surg. 1919;141:334–8.

    Article  Google Scholar 

  347. Bumaschny E, et al. Postoperative acute gastrointestinal tract hemorrhage and multiple-organ failure. Arch Surg. 1988;123(6):722–6.

    Article  CAS  PubMed  Google Scholar 

  348. Etemad B. Gastrointestinal complications of renal failure. Gastroenterol Clin N Am. 1998;27(4):875–92.

    Article  CAS  Google Scholar 

  349. Tani N, et al. Lesions of the upper gastrointestinal tract in patients with chronic renal failure. Gastroenterol Jpn. 1980;15(5):480–4.

    Article  CAS  PubMed  Google Scholar 

  350. Jaffe RH, Laing DR. Changes of the digestive tract in uremia; pathologic anatomy study. Arch Intern Med. 1934;53:851–64.

    Article  Google Scholar 

  351. Mason EE. Gastrointestinal lesions occurring in uremia. Ann Intern Med. 1952;37(1):96–105.

    Article  CAS  PubMed  Google Scholar 

  352. Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci. 1993;38(2):257–68.

    Article  CAS  PubMed  Google Scholar 

  353. Goldstein H, et al. Gastric acid secretion in patients undergoing chronic dialysis. Arch Intern Med. 1967;120(6):645–53.

    Article  CAS  PubMed  Google Scholar 

  354. Doherty CC, McGeown MG. Peptic ulceration, gastric secretion, and renal transplantation. Br Med J. 1977;2(6080):188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  355. Milito G, et al. The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int Suppl. 1985;17:S157–60.

    CAS  PubMed  Google Scholar 

  356. Kang JY, et al. Erosive prepyloric changes in patients with end-stage renal failure undergoing maintenance dialysis treatment. Scand J Gastroenterol. 1990;25(7):746–50.

    Article  CAS  PubMed  Google Scholar 

  357. Shousha S, et al. Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol. 1990;43(5):397–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  358. Var C, et al. The effects of hemodialysis on duodenal and gastric mucosal changes in uremic patients. Clin Nephrol. 1996;45(5):310–4.

    CAS  PubMed  Google Scholar 

  359. Khedmat H, et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc. 2007;39(4):1003–7.

    Article  CAS  PubMed  Google Scholar 

  360. Margolis DM, et al. Upper gastrointestinal disease in chronic renal failure. A prospective evaluation. Arch Intern Med. 1978;138(8):1214–7.

    Article  CAS  PubMed  Google Scholar 

  361. Musola R, et al. Prevalence of gastroduodenal lesions in uremic patients undergoing dialysis and after renal transplantation. Gastrointest Endosc. 1984;30(6):343–6.

    Article  CAS  PubMed  Google Scholar 

  362. Kang JY, et al. Prevalence of peptic ulcer in patients undergoing maintenance hemodialysis. Dig Dis Sci. 1988;33(7):774–8.

    Article  CAS  PubMed  Google Scholar 

  363. Kang JY, et al. Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol. 1999;14(8):771–8.

    Article  CAS  PubMed  Google Scholar 

  364. Boudville N. The predictable effect that renal failure has on H2 receptor antagonists – increasing the half-life along with increasing prescribing errors. Nephrol Dial Transplant. 2005;20(11):2315–7.

    Article  CAS  PubMed  Google Scholar 

  365. Stolic RV, et al. Influence of the level of renal insufficiency on endoscopic changes in the upper gastrointestinal tract. Am J Med Sci. 2008;336(1):39–43.

    Article  PubMed  Google Scholar 

  366. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol. 1997;21(1):60–9.

    Article  CAS  PubMed  Google Scholar 

  367. Abraham SC, et al. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol. 2001;25(5):637–44.

    Article  CAS  PubMed  Google Scholar 

  368. Chatelain D, et al. Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (Kayexalate). Ann Diagn Pathol. 2007;11(3):217–9.

    Article  PubMed  Google Scholar 

  369. Swanson BJ, et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 2013;37(11):1686–93.

    Article  PubMed  Google Scholar 

  370. Diamond SM, Emmett M, Henrich WL. Bowel infarction as a cause of death in dialysis patients. JAMA. 1986;256(18):2545–7.

    Article  CAS  PubMed  Google Scholar 

  371. Madden MA, et al. Acute bowel obstruction: an unusual complication of chronic peritoneal dialysis. Am J Kidney Dis. 1982;1(4):219–21.

    Article  CAS  PubMed  Google Scholar 

  372. Bargman JM. Hernias in peritoneal dialysis patients: limiting occurrence and recurrence. Perit Dial Int. 2008;28(4):349–51.

    Article  PubMed  Google Scholar 

  373. Herbstman D, Kraft SC. Extraintestinal manifestations of gastrointestinal disease and gastrointestinal manifestations of extraintestinal disease. In: Gitnik GL, editor. Current gastroenterology, vol. 6. Chicago: Year Book Medical Publichers; 1986.

    Google Scholar 

  374. Kraft SC, Wang NS. Extraintestinal manifestations of gastrointestinal disease and gastrointestinal manifestations of extraintestinal disease. In: Gitnik GL, editor. Current Gastroenterology. Boston: Houghton Mifflin; 1985. p. 299–351.

    Google Scholar 

  375. Lockyer WA, et al. An outbreak of Salmonella enteritis and septicemia in a population of uremic patients. A review of four cases, including infection of an arteriovenous fistula. Arch Intern Med. 1980;140(7):943–5.

    Article  CAS  PubMed  Google Scholar 

  376. Young R, Bryk D. Colonic intussusception in uremia. Am J Gastroenterol. 1979;71(2):229–32.

    Article  CAS  PubMed  Google Scholar 

  377. Tuthill MH, Stratton J, Warrens AN. Calcific uremic arteriolopathy presenting with small and large bowel involvement. J Nephrol. 2006;19(1):115–8.

    PubMed  Google Scholar 

  378. Komorowski RA, et al. Gastrointestinal complications in renal transplant recipients. Am J Clin Pathol. 1986;86(2):161–7.

    Article  CAS  PubMed  Google Scholar 

  379. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int. 2005;18(6):643–50.

    Article  PubMed  Google Scholar 

  380. Davies NM, et al. Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant. 2007;22(9):2440–8.

    Article  CAS  PubMed  Google Scholar 

  381. Dominguez Fernandez E, et al. Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease. Transpl Int. 1998;11(1):28–31.

    Article  CAS  PubMed  Google Scholar 

  382. Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32(9):1367–72.

    Article  PubMed  Google Scholar 

  383. Nguyen T, et al. Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract. Am J Surg Pathol. 2009;33(9):1355–63.

    Article  PubMed  Google Scholar 

  384. Deshpande V. IgG4-related disease of the gastrointestinal tract: a 21st Century Chameleon. Arch Pathol Lab Med. 2015;139(6):742–9.

    Article  CAS  PubMed  Google Scholar 

  385. Finkelberg DL, et al. Autoimmune pancreatitis. N Engl J Med. 2006;355(25):2670–6.

    Article  CAS  PubMed  Google Scholar 

  386. Zen Y, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28(9):1193–203.

    Article  PubMed  Google Scholar 

  387. Deshpande V, et al. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol. 2009;22(10):1287–95.

    Article  CAS  PubMed  Google Scholar 

  388. Zen Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20(8):884–94.

    Article  PubMed  Google Scholar 

  389. Koizumi S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases? World J Gastroenterol. 2013;19(35):5769–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  390. Wong DD, et al. IgG4-related sclerosing disease of the small bowel presenting as necrotizing mesenteric arteritis and a solitary jejunal ulcer. Am J Surg Pathol. 2012;36(6):929–34.

    Article  PubMed  Google Scholar 

  391. Clayton F, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602–9.

    Article  CAS  PubMed  Google Scholar 

  392. Geyer JT, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34(2):202–10.

    Article  PubMed  Google Scholar 

  393. Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43(6):806–17.

    Article  CAS  PubMed  Google Scholar 

  394. Fujimori N, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013;19(1):35–41.

    Article  PubMed  PubMed Central  Google Scholar 

  395. Kuroda N, et al. Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Med Mol Morphol. 2009;42(4):236–8.

    Article  CAS  PubMed  Google Scholar 

  396. Petre S, Shah IA, Gilani N. Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy. Aliment Pharmacol Ther. 2008;27(11):1006–16.

    Article  CAS  PubMed  Google Scholar 

  397. Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980;302(24):1333–43.

    Article  CAS  PubMed  Google Scholar 

  398. Friedman S, Janowitz HD. Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin N Am. 1998;27(3):595–614.

    Article  CAS  Google Scholar 

  399. Kisslevsky R. Amyloidosis: a familiar problem in the light of current pathogenic developments. Lab Investig. 1983;49:381–90.

    Google Scholar 

  400. Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2008;103(3):776–87.

    Article  PubMed  Google Scholar 

  401. Kumar SS, et al. Amyloidosis of the colon. Report of a case and review of the literature. Dis Colon Rectum. 1983;26(8):541–4.

    Article  CAS  PubMed  Google Scholar 

  402. Shimizu S, et al. A case of primary amyloidosis confined to the small intestine. Gastroenterol Jpn. 1986;21(5):513–7.

    Article  CAS  PubMed  Google Scholar 

  403. Bjornsson S, Johannsson JH, Sigurjonsson F. Localized primary amyloidosis of the stomach presenting with gastric hemorrhage. Acta Med Scand. 1987;221(1):115–9.

    Article  CAS  PubMed  Google Scholar 

  404. Garcia-Gonzalez R, et al. Amyloidosis of the rectum mimicking collagenous colitis. Pathol Res Pract. 1998;194(10):731–5.

    Article  CAS  PubMed  Google Scholar 

  405. Sun W, et al. The successful diagnosis and typing of systemic amyloidosis using a microwave-assisted filter-aided fast sample preparation method and LC/MS/MS analysis. PLoS One. 2015;10(5):–e0127180.

    Google Scholar 

  406. Pettersson T, Konttinen YT. Amyloidosis-recent developments. Semin Arthritis Rheum. 2010;39(5):356–68.

    Article  CAS  PubMed  Google Scholar 

  407. Kyle RA, Greipp PR, Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983;58(10):665–83.

    CAS  PubMed  Google Scholar 

  408. Yamada M, Hatakeyama S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum Pathol. 1985;16(12):1206–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclaimer

The authors agree to the fact that all biopsy procedures and surgical resections were performed after taking informed consent from respective patients as per the individual Institutional policies, which also includes consent for publishing the unidentified clinical images for publication or research purposes. The authors also declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, El Camino Hospital, Mountain View, CA, USA

    Natalie Patel

  2. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  3. Department of Pathology, Yale University School of Medicine, New Haven, CT, USA

    Dhanpat Jain

Authors
  1. Natalie Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prasenjit Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dhanpat Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dhanpat Jain .

Editor information

Editors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  2. Department of Pathology, Al Sabah Hospital, Kuwait City, Kuwait

    Kaushik Majumdar

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Siddhartha Datta Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patel, N., Das, P., Jain, D. (2022). Systemic Manifestations of Gastrointestinal Tract Diseases and Systemic Diseases Involving the Gastrointestinal Tract. In: Das, P., Majumdar, K., Datta Gupta, S. (eds) Surgical Pathology of the Gastrointestinal System. Springer, Singapore. https://doi.org/10.1007/978-981-16-6395-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6395-6_14

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6394-9

  • Online ISBN: 978-981-16-6395-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation